Results 161 to 170 of about 103,481 (331)

Erratum to Current status of dopamine agonists in Parkinson’s disease [PDF]

, 1996
J L Montastruc, Olivier Rascol, Jean‐Michel Sénard   +2 more
openalex   +1 more source

Behavioral studies of the effects of dopamine and 5-HT1A agonists in cynomolgus monkeys

, 1989
Eiji Mizuta, Motonori Yamaguchi, Sadako Kuno   +2 more
openalex   +1 more source

Efficacy and Safety of IncobotulinumtoxinA for Treatment of Sialorrhea: A Multicenter, Phase 3 Study in Japan

Movement Disorders Clinical Practice, EarlyView.
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori, Yohei Mukai, Noriko Nishikawa, Kazuko Hasegawa, Masahiko Tomiyama, Yasuyoshi Kimura, Yoshio Tsuboi, Ryosuke Takahashi, Ryota Nakamura, Yuishin Izumi, Hirohisa Watanabe, Morinobu Seki, Kenji Sekiguchi, Shohei Tateishi, Yusaku Matsushita, Yusaku Nakamura   +15 more
wiley   +1 more source

Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach

, 1990
Romain A. Lefebvre, Fouzia Guenaneche, Freya A. De Beurme   +2 more
openalex   +2 more sources

Distinction and mutual Influences between Parkinson's Disease‐related and unrelated Chronic Pain

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Chronic pain (i.e. > 3 months) is a common nonmotor symptom in patients with Parkinson's disease (PD), but the attribution to PD is critical for further treatment. Objectives We explored the PD Pain Classification System (PD‐PCS) criteria for the diagnosis of PD‐related pain and mutual influences between PD‐related and PD‐unrelated ...
Jonathan Hunger, Florian Brugger, Georg Kägi, Jens Carsten Möller, Nathalie Hollenstein, David H. Benninger, Michele Tinazzi, Julien F. Bally, Roman Gonzenbach, Daniel Ciampi de Andrade, Santiago Perez Lloret, Veit Mylius   +11 more
wiley   +1 more source

Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson's Disease. [PDF]

Curr Neuropharmacol, 2023
Jing XZ, Yang HJ, Taximaimaiti R, Wang XP.   +3 more
europepmc   +1 more source

Fenoldopam, a Dopamine Agonist, for Hypertensive Emergency: A Multicenter Randomized Trial [PDF]

, 2000
James A. Tumlin, Lala M. Dunbar, Suzanne Oparil, Vardaman M. Buckalew, C. Venkata S. Ram, Vandana Mathur, David Ellis, Dawn McGuire, J. D. FELLMANN, Robert R. Luther   +9 more
openalex   +1 more source

Examining Device Usage Patterns in Outpatient Telemedicine Video Visits among Movement Disorders Patients

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Telemedicine has improved access to care, yet device usage for virtual visits remains underexplored. Objective To characterize device usage patterns for video televisits across sociodemographic factors in a tertiary Movement Disorders clinic in the United States.
Mitra Afshari, Vijay G. Palakuzhy, Bichun Ouyang, Glenn T. Stebbins, Christopher G. Goetz   +4 more
wiley   +1 more source

Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms. [PDF]

Front Endocrinol (Lausanne), 2021
Pivonello C, Patalano R, Negri M, Pirchio R, Colao A, Pivonello R, Auriemma RS.   +6 more
europepmc   +1 more source

GABA in the Deep Layers of the Superior Colliculus/Mesencephalic Reticular Formation Mediates the Enhancement of Startle by the Dopamine D₁Receptor Agonist SKF 82958 in Rats [PDF]

, 2000
Edward G. Meloni, Michael J. Davis
openalex   +1 more source